Apex Healthcare Berhad (KLSE: AHEALTH)

Market Cap	1.94B
Revenue (ttm)	962.25M
Net Income (ttm)	89.08M
Shares Out	720.06M
EPS (ttm)	0.12
PE Ratio	21.60
Forward PE	20.89
Dividend	0.26 (9.59%)
Ex-Dividend Date	Sep 5, 2024

Volume	128,400
Open	2.700
Previous Close	2.700
Day's Range	2.680 - 2.710
52-Week Range	2.380 - 3.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2024

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates through three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, o...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2023, Apex Healthcare Berhad's revenue was 936.17 million, an increase of 6.66% compared to the previous year's 877.74 million. Earnings were 397.99 million, an increase of 294.15%.